Chronic myelocytic leukemia (CML) is a clonal myeloproliferative disorder of hematopoietic stem cell (HSC), which is mainly driven by the fusion gene BCR-ABL1, a product of the Philadelphia chromosome (Ph) 1. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.